[HTML][HTML] Anticachectic regulator analysis reveals Perp-dependent antitumorigenic properties of 3-methyladenine in pancreatic cancer
A Dasgupta, PC Arneson-Wissink, RE Schmitt… - JCI insight, 2022 - ncbi.nlm.nih.gov
Approximately 80% of pancreatic cancer patients suffer from cachexia, and one-third die due
to cachexia-related complications such as respiratory failure and cardiac arrest. Although …
to cachexia-related complications such as respiratory failure and cardiac arrest. Although …